6HM-31309-74034
3 vaccinations
1 coded response
36 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 631 / MO
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-29
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-11-17
Dose 3 — Pfizer-BioNTech
- 2021-11-17
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-11-19
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Axillary pain on injection sideMedDRA releases: 2024-11 · check-in free text available
- 2021-11-20
- 2021-11-21
- 2021-11-22
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-26
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-22
- 2021-12-31
- 2022-02-16
- 2022-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-11-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary pain on injection side
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release